Sidra to host inaugural MENA ART meet
Tribune News Network
Doha
Sidra Medicine, a member of Qatar Foundation, will host its inaugural MENA ART (Advanced Research Technologies for Personalized Medicine) conference on May 18 and 19.
MENA ART will bring together leading scientists, clinicians, and industry experts from around the world to explore how flow cytometry and optical microscopy are shaping the future of precision medicine.
The theme of the conference, 'Innovation in Flow Cytometry and Optical Microscopy', will highlight how these technologies are transforming disease diagnosis, biomarker discovery, and the development of targeted therapies. It aims to foster cross-disciplinary dialogue and showcase pioneering research that is changing the landscape of healthcare.
Dr Giusy Gentilcore, Manager of the Flow Cytometry Core Facility at Sidra Medicine and co-chair of MENA ART 2025, said: 'Flow cytometry and Optical Microscopy are at the heart of many breakthroughs in immunology and personalised medicine. At MENA ART 2025, we are bringing together global experts to showcase how this powerful technology advances our understanding of diseases and improves patient outcomes. The hands-on workshops are a highlight, providing participants with the practical skills needed to maximise the impact of their research.'
The conference will feature expert-led sessions on cutting-edge applications across cancer biology, immunology, small particles, digital pathology, and translational medicine. Attendees will gain valuable insights into the latest advancements in high-throughput imaging, spatial proteomics, and single-cell analysis.
Flow cytometry is a powerful tool that enables rapid, high-dimensional cell analysis, supporting breakthroughs in diagnostics and therapeutic innovation. Whereas optical microscopy provides detailed views into cellular structures and biological processes, allowing scientists to visualise disease mechanisms, track treatment responses, and drive discovery at the molecular level.
Dr Abbirami Sathappan, Lead of the Advanced Imaging Core at Sidra Medicine, said: 'The MENA ART 2025 conference represents a unique platform for researchers, clinicians, and technology leaders to exchange ideas and explore the latest innovations in imaging. By focusing on the real-world impact of optical microscopy in diagnostics and translational research, we aim to drive meaningful conversations that inspire collaboration and accelerate scientific progress in the region and beyond.'
In addition to the main conference, Sidra Medicine will host the region's first hands-on workshop of its kind from May 20–22, offering participants an immersive experience in flow cytometry and optical microscopy
technologies.
Led by expert instructors from around the world, the workshop will feature high-end demo equipment alongside cutting-edge platforms from our own laboratories. Participants will gain direct, practical training in data acquisition, analysis, and interpretation, building essential skills to advance precision medicine research.
The MENA ART conference highlights Sidra Medicine's role in advancing precision medicine through research, innovation and collaboration.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
7 hours ago
- Qatar Tribune
‘QF's inclusive education framework benefits students in and out of class'
Tribune News Network Doha Within the unique learning environment of Qatar Foundation (QF), its landscape of pre-university education breaks new ground in meeting the diverse needs of all students, including those facing learning challenges, but also those who demonstrate advanced abilities. Through carefully designed curricula, specialised programmes, and integrated support from its support services department The Learning Center, Qatar Foundation's Pre-University Education division aims to empower every studentto discover their potential and thrive 'QF has played a huge role in my growth, both in and out of the classroom,' said Amina Yasser Ahmed, a student at QF's Qatar Academy for Science and Technology (QAST), – where she was President of its Model United Nations club – and a high academic achiever. 'Academically, the rigorous curriculum, access to advanced courses, and encouragement to take on challenges helped me push my limits and strive for excellence. 'Personally, QF's diverse and inclusive environment exposed me to a wide range of cultures and perspectives, which helped me become more open-minded, empathetic, and confident in expressing myself. It also gave me the space to explore my interests, like medicine and scientific research.' Ahmed, who had the opportunity to experience research at QF's Sidra Medicine and Qatar Biomedical Research Institute (QBRI), part of QF's Hamad Bin Khalifa University, explained that her school offered strong support throughout her research journey. 'The guidance and the flexibility of my teachers and staff helped me balance my academic workload with research responsibilities,' she said. 'QF creates a learning environment that values every student's unique strength. This inclusive and supportive culture helped all of us feel valued, regardless of ouracademic path strengths, and taught us to respect and celebrate each other's contributions.' Reem Jamal S. Al Kaabi, a public speaker, young entrepreneur, and student at QF's Qatar Academy for Science and Technology (QAST), said, 'As a student leader, I was given opportunities to lead people who shared my passion and ambition to make a difference. The QF environment encourages ambition and gives young people the space to express themselves and take action.' Al Kaabi said this helped her apply what she learned in the classroom to real life, whether through establishing student initiatives like the Medicine Club at Education City High School – which is comprised of three QF schools: QAST, Qatar Academy Doha, and Qatar Academy Sidra – or speaking at conferences such as KidZania Zummit 2025. 'As part of QAST's inclusive school environment, I felt understood as a person, not just an outstanding student,' she explained. 'I was surrounded by peers and teachers who celebrated differences, not just excellence, and this allowed me to thrive without having to 'fit in'.' Al Kaabi, who represented Qatar at the First Gulf Forum for Gifted Students 2024 in Kuwait with the Ministry of Education and Higher Education, explained: 'QAST has always encouraged me to think outside the box and see the true value of what I do. Our school-based initiatives have helped me develop essential workplaceskills, including public speaking.' Saifuddin Aftab, a teacher and STEM coordinator at QAST, relies on a holistic approach to teaching, which guides his teaching and interactions with students in the classroom. For him, it all begins with building strong relationships, understanding students' needs, and ensuring they feel safe and comfortable. 'I leverage my academic expertise to provide appropriate learning challenges, using individualised strategies that enable each student to understand the content and make progress,' he said. 'I also ensure that students are assigned according to their needs, allowing them todevelop at their own pace.'
Qatar Tribune
5 days ago
- Qatar Tribune
Sidra Medicine first hospital in ME to successfully perform Intraventricular Baclofen Therapy
Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, is the first hospital in the Middle East to successfully perform two Intraventricular Baclofen Therapies. The milestone highlights Sidra Medicine's commitment to pioneering advanced neurosurgical treatments for children and young people with severe movement disorders. The procedure was performed on two young people with Dystonia. Dystonia is a neurological condition that causes uncontrolled muscle contractions. Following the procedure at Sidra Medicine, both adolescents experienced a remarkable improvement in their condition, demonstrating the effectiveness of this innovative therapy. Dr. Ian Pople, chief of Neurosurgery at Sidra Medicine, who led the procedure and emphasised its significance, said: 'The neurosurgery performed on both patients was highly successful. Unlike traditional intrathecal Baclofen therapy, which delivers the drug into the spinal fluid via a pump in the lower back, the intraventricular approach administers the medication directly into the brain's ventricles, allowing for more effective treatment of severe dystonia affecting the entire body. This approach underscores the importance of integrating neurosurgical precision with rehabilitation, ensuring patients receive the most advanced care available.' Innovative Treatment Approach Intraventricular Baclofen Therapy begins with the placement of a ventricular reservoir to allow for a trial of Baclofen therapy. This minimally invasive procedure is performed in the operating room using neuronavigational equipment, and the patient stays overnight for monitoring. Once the surgical site has healed, the patient undergoes a three-day trial in the neurosurgical ward, where an external pump delivers Baclofen similarly to the fully implanted device. Regular assessments help determine the patient's response to the medication. If the trial is successful, a permanent Baclofen pump is implanted to provide continuous therapy. The dosage is gradually adjusted to optimise symptom control, significantly improving the patient's quality of life. Qatar's First Paediatric Movement Disorders Clinic Sidra Medicine features Qatar's first paediatric-focused Movement Disorders Clinic, offering advanced care for children and young people with spasticity (uncontrollable muscle stiffness) and dystonia. The clinic takes a multidisciplinary approach, with specialists in rehabilitation medicine, neurology, neurosurgery, and therapy. It provides surgical and non-surgical interventions for patients who have not responded to medications and conventional therapy. The clinic is a key part of Sidra Medicine's commitment to pioneering pediatric neurology care. Adam's Journey: A Life Transformed Adam was one of the young patients who underwent the groundbreaking Intraventricular Baclofen Therapies at Sidra Medicine. Speaking about the impact of the treatment, Adam's mother said, 'Before the surgery, Adam's condition affected nearly every part of his day. His limbs moved constantly, making it difficult for him to concentrate, rest, or participate in school like other children his age. 'After his surgery at Sidra Medicine and thanks to the Movement Disorders Clinic, Adam's movements began to settle, and he gained a level of control we had not seen in years. These small improvements transformed how he interacts with the world. It has brought hope back into our home, and I truly believe this procedure and the supporting rehabilitative support can help many more children like Adam.' Comprehensive Neurosurgical Care at Sidra Medicine Sidra Medicine's Neurosurgery Department specialises in treating a wide range of neurological conditions, including hydrocephalus, congenital abnormalities, brain and spinal tumours, epilepsy, craniofacial disorders, and spinal conditions. The hospital's use of cutting-edge technology, combined with a patient-centred approach, ensures that children receive world-class care tailored to their individual needs. For international inquiries about Sidra Medicine's Neurosurgery services, contact
Qatar Tribune
6 days ago
- Qatar Tribune
Sidra Medicine becomes first hospital in Middle East to successfully perform Intraventricular Baclofen Therapy
DOHA: Sidra Medicine, a member of Qatar Foundation, is the first hospital in the Middle East to successfully perform two Intraventricular Baclofen Therapies. The milestone highlights Sidra Medicine's commitment to pioneering advanced neurosurgical treatments for children and young people with severe movement disorders. The procedure was performed on two young people with Dystonia. Dystonia is a neurological condition that causes uncontrolled muscle contractions. Following the procedure at Sidra Medicine, both adolescents experienced a remarkable improvement in their condition, demonstrating the effectiveness of this innovative therapy. Dr Ian Pople, Chief of Neurosurgery at Sidra Medicine, who led the procedure and emphasized its significance said: "The neurosurgery performed on both patients was highly successful. Unlike traditional intrathecal Baclofen therapy, which delivers the drug into the spinal fluid via a pump in the lower back, the intraventricular approach administers the medication directly into the brain's ventricles, allowing for more effective treatment of severe dystonia affecting the entire body. This approach underscores the importance of integrating neurosurgical precision with rehabilitation, ensuring patients receive the most advanced care available." Intraventricular Baclofen Therapy begins with the placement of a ventricular reservoir to allow for a trial of Baclofen therapy. This minimally invasive procedure is performed in the operating room using neuronavigational equipment, and the patient stays overnight for monitoring. Once the surgical site has healed, the patient undergoes a three-day trial in the neurosurgical ward, where an external pump delivers Baclofen similarly to the fully implanted device. Regular assessments help determine the patient's response to the medication. If the trial is successful, a permanent Baclofen pump is implanted to provide continuous therapy. The dosage is gradually adjusted to optimize symptom control, significantly improving the patient's quality of life. Sidra Medicine features Qatar's first pediatric-focused Movement Disorders Clinic, offering advanced care for children and young people with spasticity (uncontrollable muscle stiffness) and dystonia. The clinic takes a multidisciplinary approach, with specialists in rehabilitation medicine, neurology, neurosurgery, and therapy. It provides surgical and non-surgical interventions for patients who have not responded to medications and conventional therapy. The clinic is a key part of Sidra Medicine's commitment to pioneering pediatric neurology care. Adam was one of the young patients who underwent the groundbreaking Intraventricular Baclofen Therapies at Sidra Medicine. Speaking about the impact of the treatment, Adam's mother said: "Before the surgery, Adam's condition affected nearly every part of his limbs moved constantly, making it difficult for him to concentrate, rest, or participate in school like other children his age." "After his surgery at Sidra Medicine and thanks to the Movement Disorders Clinic, Adam's movements began to settle, and he gained a level of control we had not seen in years. These small improvements transformed how he interacts with the world. It has brought hope back into our home, and I truly believe this procedure and the supporting rehabilitative support can help many more children like Adam," she added. Sidra Medicine's Neurosurgery Department specializes in treating a wide range of neurological conditions, including hydrocephalus, congenital abnormalities, brain and spinal tumors, epilepsy, craniofacial disorders, and spinal conditions. The hospital's use of cutting-edge technology, combined with a patient-centered approach, ensures that children receive world-class care tailored to their individual needs.
